Published in Genes Chromosomes Cancer on July 01, 2009
MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem (2010) 2.85
MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLoS One (2010) 1.89
Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors. Cancer Res (2010) 1.80
miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC). Br J Cancer (2010) 1.61
MicroRNA-125b potentiates macrophage activation. J Immunol (2011) 1.47
Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br J Cancer (2011) 1.42
MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion. J Biol Chem (2012) 1.39
ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines. Br J Cancer (2010) 1.38
Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells. Genes Chromosomes Cancer (2010) 1.27
MicroRNA expression profiling of oligodendrocyte differentiation from human embryonic stem cells. PLoS One (2010) 1.24
MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma. PLoS One (2011) 1.23
MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas. J Oral Maxillofac Res (2013) 1.22
Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. J Hepatol (2011) 1.20
Good guy or bad guy: the opposing roles of microRNA 125b in cancer. Cell Commun Signal (2014) 1.15
NF-κB and cancer: a paradigm of Yin-Yang. Am J Cancer Res (2010) 1.08
Ablation of Dicer from murine Schwann cells increases their proliferation while blocking myelination. PLoS One (2010) 1.07
MTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b. J Exp Clin Cancer Res (2013) 1.05
Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway. Oncogene (2013) 1.05
Subsite-based alterations in miR-21, miR-125b, and miR-203 in squamous cell carcinoma of the oral cavity and correlation to important target proteins. J Carcinog (2012) 1.01
microRNA-125b inhibits cell migration and invasion by targeting matrix metallopeptidase 13 in bladder cancer. Oncol Lett (2013) 1.01
Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer. Diagn Pathol (2012) 1.01
Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue. Cancer Prev Res (Phila) (2013) 1.01
Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases. Front Cell Dev Biol (2014) 0.99
Pre-microRNA variants predict HPV16-positive tumors and survival in patients with squamous cell carcinoma of the oropharynx. Cancer Lett (2012) 0.96
Overexpression of KLF13 and FGFR3 in oral cancer cells. Cytogenet Genome Res (2010) 0.96
MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5. Oncotarget (2015) 0.96
miR-125b can enhance skin tumor initiation and promote malignant progression by repressing differentiation and prolonging cell survival. Genes Dev (2014) 0.94
MicroRNA100 inhibits self-renewal of breast cancer stem-like cells and breast tumor development. Cancer Res (2014) 0.93
MiR-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosis. Gastric Cancer (2014) 0.93
MicroRNAs - Biology and clinical applications. J Oral Maxillofac Pathol (2014) 0.93
Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome. PLoS One (2011) 0.92
MicroRNA Role in Thyroid Cancer Development. J Thyroid Res (2011) 0.91
MicroRNAs MiR-218, MiR-125b, and Let-7g predict prognosis in patients with oral cavity squamous cell carcinoma. PLoS One (2014) 0.91
MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways. PLoS One (2013) 0.90
MiR-429 inhibits oral squamous cell carcinoma growth by targeting ZEB1. Med Sci Monit (2015) 0.89
MicroRNAs in Head and Neck Cancer. Int J Dent (2013) 0.88
Upregulation of microRNA-100 predicts poor prognosis in patients with pediatric acute myeloid leukemia. Onco Targets Ther (2012) 0.87
miR-125b promotes cell death by targeting spindle assembly checkpoint gene MAD1 and modulating mitotic progression. Cell Death Differ (2012) 0.87
MicroRNA-99 family members suppress Homeobox A1 expression in epithelial cells. PLoS One (2013) 0.87
Expression profiling of exosomal miRNAs derived from human esophageal cancer cells by Solexa high-throughput sequencing. Int J Mol Sci (2014) 0.87
MicroRNA-125b transforms myeloid cell lines by repressing multiple mRNA. Haematologica (2012) 0.86
Effects of β4 integrin expression on microRNA patterns in breast cancer. Biol Open (2012) 0.85
Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2. Dig Dis Sci (2014) 0.85
Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma. Oncogene (2015) 0.85
By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy. Oncotarget (2015) 0.83
MicroRNA variants increase the risk of HPV-associated squamous cell carcinoma of the oropharynx in never smokers. PLoS One (2013) 0.82
miRNAs Signature in Head and Neck Squamous Cell Carcinoma Metastasis: A Literature Review. J Dent (Shiraz) (2016) 0.82
MicroRNAs in Head and Neck Squamous Cell Carcinoma (HNSCC) and Oral Squamous Cell Carcinoma (OSCC). Cancers (Basel) (2010) 0.81
The role of miRNAs in cutaneous squamous cell carcinoma. J Cell Mol Med (2015) 0.81
MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma. J Oncol (2011) 0.80
The role and expression of miR-100 and miR-203 profile as prognostic markers in epithelial ovarian cancer. Am J Transl Res (2016) 0.79
The involvement of miR-100 in bladder urothelial carcinogenesis changing the expression levels of mRNA and proteins of genes related to cell proliferation, survival, apoptosis and chromosomal stability. Cancer Cell Int (2014) 0.79
A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas. J Exp Clin Cancer Res (2016) 0.79
miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation. Oncogene (2016) 0.77
Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss. Genes Chromosomes Cancer (2013) 0.77
Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy. Oncotarget (2016) 0.77
Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones. BMC Cancer (2016) 0.76
Prognostic significance of microRNA-100 in solid tumors: an updated meta-analysis. Onco Targets Ther (2017) 0.75
Pre-miRNA variants as predictors of clinical outcome in patients with squamous cell carcinomas of the nonoropharynx. Oncotarget (2016) 0.75
Predicting associations between microRNAs and target genes in breast cancer by bioinformatics analyses. Oncol Lett (2016) 0.75
Elevated microRNA-125b levels predict a worse prognosis in HER2-positive breast cancer patients. Oncol Lett (2016) 0.75
Lymph node or perineural invasion is associated with low miR-15a, miR-34c and miR-199b levels in head and neck squamous cell carcinoma. BBA Clin (2016) 0.75
Lower Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Promotes the Proliferation and Migration of Endometrial Carcinoma. Med Sci Monit (2017) 0.75
Association between polymorphisms in pre-miRNA genes and risk of oral squamous cell cancer in a Chinese population. PLoS One (2017) 0.75
MicroRNA-125b targeted STAT3 to inhibit laryngeal squamous cell carcinoma cell growth and motility. Oncol Lett (2017) 0.75
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature (2005) 48.95
A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A (2006) 40.09
miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res (2006) 39.25
A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science (2001) 31.33
The microRNA Registry. Nucleic Acids Res (2004) 29.45
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A (2004) 28.29
MicroRNA gene expression deregulation in human breast cancer. Cancer Res (2005) 27.56
GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol (2003) 22.63
MicroRNA genes are transcribed by RNA polymerase II. EMBO J (2004) 20.65
Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature (2000) 19.15
Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet (2002) 17.20
Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell (2005) 15.26
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature (2007) 15.20
Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol (2004) 15.15
Processing of primary microRNAs by the Microprocessor complex. Nature (2004) 14.59
Phylogenetic shadowing and computational identification of human microRNA genes. Cell (2005) 13.24
Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA (2004) 11.52
microRNAs as oncogenes and tumor suppressors. Dev Biol (2006) 10.68
The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res (2007) 9.32
Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell (2005) 9.27
Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA (2004) 8.31
Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol (2007) 8.05
MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res (2008) 7.45
MicroRNA-cancer connection: the beginning of a new tale. Cancer Res (2006) 7.38
RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol (2006) 6.81
Widespread deregulation of microRNA expression in human prostate cancer. Oncogene (2007) 5.70
MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res (2008) 5.54
Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res (2008) 5.46
Regulation of miRNA expression during neural cell specification. Eur J Neurosci (2005) 5.27
MicroRNAs as oncogenes. Curr Opin Genet Dev (2005) 4.54
Micro-RNA regulation of the mammalian lin-28 gene during neuronal differentiation of embryonal carcinoma cells. Mol Cell Biol (2005) 4.19
From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci U S A (2005) 4.16
Small regulatory RNAs in mammals. Hum Mol Genet (2005) 4.15
Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer (2005) 3.80
MicroRNAs and their regulatory roles in animals and plants. J Cell Physiol (2007) 3.38
MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology (2008) 3.00
The role of microRNAs in cancer: no small matter. Eur J Cancer (2007) 2.85
MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun (2007) 2.75
miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun (2008) 2.16
Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene (2005) 1.81
Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol (1997) 1.79
A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res (2003) 1.78
Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Prostate (2006) 1.76
Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc Natl Acad Sci U S A (2003) 1.68
Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosomes Cancer (2006) 1.49
BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1). Oncogene (2006) 1.48
RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes. Immunity (1999) 1.48
High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci U S A (2002) 1.46
Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck (2001) 1.44
Mechanisms of disease: regulation of RANTES (CCL5) in renal disease. Nat Clin Pract Nephrol (2007) 1.43
Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth. Clin Cancer Res (2005) 1.31
Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Oncogene (1998) 1.29
Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer. J Clin Pathol (2002) 1.27
The Kruppel-like transcription factor KLF13 is a novel regulator of heart development. EMBO J (2006) 1.25
The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. Br J Cancer (1999) 1.22
ATM gene mutations result in both recessive and dominant expression phenotypes of genes and microRNAs. Am J Hum Genet (2008) 1.21
The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. Oral Oncol (2006) 1.20
The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis. J Immunother (2005) 1.17
Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma. Genes Chromosomes Cancer (2007) 1.11
High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma. J Urol (2004) 1.11
Neuropathy-associated Egr2 mutants disrupt cooperative activation of myelin protein zero by Egr2 and Sox10. Mol Cell Biol (2007) 1.10
Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma. Br J Cancer (2007) 1.09
Genes and molecular pathways related to radioresistance of oral squamous cell carcinoma cells. Int J Cancer (2007) 1.05
Array-comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas. Mol Carcinog (2006) 1.05
Lung adenocarcinoma invasion in TGFbetaRII-deficient cells is mediated by CCL5/RANTES. Oncogene (2007) 1.04
The KLF family of transcriptional regulators in cardiomyocyte proliferation and differentiation. Cell Cycle (2007) 1.03
Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature. Oral Oncol (2007) 1.02
Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma. J Pathol (2008) 0.98
Hepatocyte nuclear factor-3 alpha (HNF-3alpha) negatively regulates androgen receptor transactivation in prostate cancer cells. Biochem Biophys Res Commun (2008) 0.96
Increase of MMP-13 expression in multi-stage oral carcinogenesis and epigallocatechin-3-gallate suppress MMP-13 expression. Oral Dis (2006) 0.96
Cytogenetic abnormalities in 106 oral squamous cell carcinomas. Cancer Genet Cytogenet (2006) 0.95
FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q. Genes Chromosomes Cancer (1998) 0.95
Understanding the immunoangiostatic CXC chemokine network. Cardiovasc Res (2008) 0.94
Overexpression of cyclin D1 correlates with sensitivity to cisplatin in squamous cell carcinoma cell lines of the head and neck. Acta Otolaryngol (2004) 0.94
Relationship between FRA11F and 11q13 gene amplification in oral cancer. Genes Chromosomes Cancer (2007) 0.93
KLF13 influences multiple stages of both B and T cell development. Cell Cycle (2008) 0.91
Elevated expression of CCL5/RANTES in adult T-cell leukemia cells: possible transactivation of the CCL5 gene by human T-cell leukemia virus type I tax. Int J Cancer (2004) 0.90
In situ expression of IFN-gamma-inducible T cell alpha chemoattractant in breast cancer mounts an enhanced specific anti-tumor immunity which leads to tumor regression. Cancer Immunol Immunother (2007) 0.90
Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture. Cancer Immunol Immunother (2006) 0.86
Interaction of PRP4 with Kruppel-like factor 13 regulates CCL5 transcription. J Immunol (2007) 0.84
A metalloproteinase-13 polymorphism affecting its gene expression is associated with advanced stages of oral cancer. Anticancer Res (2008) 0.79
Id proteins are overexpressed in human oral squamous cell carcinomas. J Oral Pathol Med (2003) 0.79
Fibroblast growth factor receptor 3 S249C mutation in virus associated squamous cell carcinomas. Oncol Rep (2001) 0.77
Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet (2011) 8.57
Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet (2012) 3.68
The Gene, Environment Association Studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions. Genet Epidemiol (2010) 3.48
Spindle multipolarity is prevented by centrosomal clustering. Science (2005) 3.10
Comprehensive literature review and statistical considerations for microarray meta-analysis. Nucleic Acids Res (2012) 2.54
Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head Neck (2007) 2.49
Association tests using kernel-based measures of multi-locus genotype similarity between individuals. Genet Epidemiol (2010) 2.39
Somatic mutation and gain of copy number of PIK3CA in human breast cancer. Breast Cancer Res (2005) 2.20
Genetic analysis of variation in human meiotic recombination. PLoS Genet (2009) 2.11
TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. Cancer Res (2012) 1.98
What's the best statistic for a simple test of genetic association in a case-control study? Genet Epidemiol (2010) 1.95
Regression-based quantitative-trait-locus mapping in the 21st century. Am J Hum Genet (2002) 1.87
Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis. Sci Transl Med (2013) 1.81
Comprehensive literature review and statistical considerations for GWAS meta-analysis. Nucleic Acids Res (2012) 1.75
Resolution of anaphase bridges in cancer cells. Chromosoma (2004) 1.72
New insights into human nondisjunction of chromosome 21 in oocytes. PLoS Genet (2008) 1.68
Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells. Cancer Res (2006) 1.60
Uncommon mutation, but common amplifications, of the PIK3CA gene in thyroid tumors. J Clin Endocrinol Metab (2005) 1.51
Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. Cancer Res (2010) 1.51
Global transcriptional response to mammalian temperature provides new insight into Francisella tularensis pathogenesis. BMC Microbiol (2008) 1.49
Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosomes Cancer (2006) 1.49
A stochastic model for cancer stem cell origin in metastatic colon cancer. Cancer Res (2008) 1.48
High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci U S A (2002) 1.46
Replication of a genome-wide association study of birth weight in preterm neonates. J Pediatr (2011) 1.45
Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma. Hum Pathol (2006) 1.41
Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis. Eur J Cancer (2005) 1.36
A Serratia marcescens OxyR homolog mediates surface attachment and biofilm formation. J Bacteriol (2007) 1.27
Association between maternal age and meiotic recombination for trisomy 21. Am J Hum Genet (2004) 1.23
Modulation of virulence factors in Francisella tularensis determines human macrophage responses. Microb Pathog (2007) 1.22
The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. Oral Oncol (2006) 1.20
Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer. Carcinogenesis (2006) 1.19
GJC2 missense mutations cause human lymphedema. Am J Hum Genet (2010) 1.17
Francisella tularensis DeltapyrF mutants show that replication in nonmacrophages is sufficient for pathogenesis in vivo. Infect Immun (2010) 1.17
Skeletal muscle fatigue, strength, and quality in the elderly: the Health ABC Study. J Appl Physiol (1985) (2005) 1.15
Recent advances in human quantitative-trait-locus mapping: comparison of methods for discordant sibling pairs. Am J Hum Genet (2003) 1.14
Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with Down syndrome. Genet Epidemiol (2010) 1.14
The cyclic AMP-dependent catabolite repression system of Serratia marcescens mediates biofilm formation through regulation of type 1 fimbriae. Appl Environ Microbiol (2008) 1.12
Etiology of Down syndrome: Evidence for consistent association among altered meiotic recombination, nondisjunction, and maternal age across populations. Am J Med Genet A (2009) 1.11
Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma. Genes Chromosomes Cancer (2007) 1.11
Recent advances in human quantitative-trait-locus mapping: comparison of methods for selected sibling pairs. Am J Hum Genet (2003) 1.09
Global transcriptional response to spermine, a component of the intramacrophage environment, reveals regulation of Francisella gene expression through insertion sequence elements. J Bacteriol (2009) 1.09
Chemosensitization of head and neck cancer cells by PUMA. Mol Cancer Ther (2007) 1.09
Footer: a quantitative comparative genomics method for efficient recognition of cis-regulatory elements. Genome Res (2005) 1.09
Heritable patterns of tooth decay in the permanent dentition: principal components and factor analyses. BMC Oral Health (2012) 1.07
Genetic variation in fatty acid-binding protein-4 and peroxisome proliferator-activated receptor gamma interactively influence insulin sensitivity and body composition in males. Metabolism (2004) 1.07
Genome-wide association scan of dental caries in the permanent dentition. BMC Oral Health (2012) 1.06
Knowledge about human papillomavirus and the HPV vaccine--a survey of the general population. Infect Agent Cancer (2009) 1.06
SNPs made routine. Nat Methods (2004) 1.04
Linkage disequilibrium mapping in trisomic populations: analytical approaches and an application to congenital heart defects in Down syndrome. Genet Epidemiol (2004) 1.03
Referral to cancer genetic counseling: are there stages of readiness? Am J Med Genet C Semin Med Genet (2006) 1.02
Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature. Oral Oncol (2007) 1.02
An excess of deleterious variants in VEGF-A pathway genes in Down-syndrome-associated atrioventricular septal defects. Am J Hum Genet (2012) 1.01
Comparisons of high-risk cervical HPV infections in Caribbean and US populations. Infect Agent Cancer (2009) 1.01
Genetics. Genetic control of hotspots. Science (2010) 1.01
Utilization of an unstable plasmid and the I-SceI endonuclease to generate routine markerless deletion mutants in Francisella tularensis. J Microbiol Methods (2009) 1.00
Catabolite repression control of flagellum production by Serratia marcescens. Res Microbiol (2008) 0.99
Chondromyxoid fibroma of rib with a novel chromosomal translocation: a report of four additional cases at unusual sites. Diagn Pathol (2007) 0.99
Altered patterns of multiple recombinant events are associated with nondisjunction of chromosome 21. Hum Genet (2011) 0.99
FOOTER: a web tool for finding mammalian DNA regulatory regions using phylogenetic footprinting. Nucleic Acids Res (2005) 0.99
Polymorphisms in DNA damage response genes and head and neck cancer risk. Biomarkers (2010) 0.98
Mass spectral determination of fasting tear glucose concentrations in nondiabetic volunteers. Clin Chem (2007) 0.98
Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. Int J Cancer (2004) 0.97
Cigarette smoke induces anaphase bridges and genomic imbalances in normal cells. Mutat Res (2004) 0.97
Invasion of erythrocytes by Francisella tularensis. J Infect Dis (2011) 0.95
Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer. Mol Cell Proteomics (2011) 0.95
Increased expression of interferon-inducible genes in macaque lung tissues during simian immunodeficiency virus infection. Microbes Infect (2006) 0.95
Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease. Neurobiol Aging (2006) 0.94
Pooling-based genome-wide association study implicates gamma-glutamyltransferase 1 (GGT1) gene in pancreatic carcinogenesis. Pancreatology (2010) 0.94
The p53-PUMA axis suppresses iPSC generation. Nat Commun (2013) 0.94
Smarter clustering methods for SNP genotype calling. Bioinformatics (2008) 0.93
Relationship between FRA11F and 11q13 gene amplification in oral cancer. Genes Chromosomes Cancer (2007) 0.93
A Francisella tularensis locus required for spermine responsiveness is necessary for virulence. Infect Immun (2011) 0.92
Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14). Hum Pathol (2004) 0.92
The origin of trisomy 22: evidence for acrocentric chromosome-specific patterns of nondisjunction. Am J Med Genet A (2007) 0.91
Genome-wide microarray expression analysis of CD4+ T Cells from nonobese diabetic congenic mice identifies Cd55 (Daf1) and Acadl as candidate genes for type 1 diabetes. J Immunol (2008) 0.91
Robust score statistics for QTL linkage analysis. Am J Hum Genet (2008) 0.90
Regulatory conservation of protein coding and microRNA genes in vertebrates: lessons from the opossum genome. Genome Biol (2007) 0.90
Genome-wide association study of periodontal health measured by probing depth in adults ages 18-49 years. G3 (Bethesda) (2014) 0.90
Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation. BMC Cancer (2009) 0.89
Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment. Clin Cancer Res (2012) 0.89
Investigation of factors associated with paternal nondisjunction of chromosome 21. Am J Med Genet A (2009) 0.89
Epidemiology of Down syndrome: new insight into the multidimensional interactions among genetic and environmental risk factors in the oocyte. Am J Epidemiol (2011) 0.89
A comparison of principal component analysis and factor analysis strategies for uncovering pleiotropic factors. Genet Epidemiol (2009) 0.88
Chromosomal fragility in patients with triple A syndrome. Am J Med Genet A (2003) 0.88
Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines. Int J Cancer (2014) 0.88
A powerful and robust new linkage statistic for discordant sibling pairs. Am J Hum Genet (2004) 0.87
Large scale comparison of innate responses to viral and bacterial pathogens in mouse and macaque. PLoS One (2011) 0.87
QTL mapping with discordant and concordant sibling pairs: new statistics and new design strategies. Genet Epidemiol (2005) 0.87
A trisomic transmission disequilibrium test. Genet Epidemiol (2004) 0.86
Genetic variation in uncoupling protein 3 is associated with dietary intake and body composition in females. Metabolism (2004) 0.86
Demographic, socioeconomic, and behavioral factors affecting patterns of tooth decay in the permanent dentition: principal components and factor analyses. Community Dent Oral Epidemiol (2012) 0.86
DLC1 is unlikely to be a primary target for deletions on chromosome arm 8p22 in head and neck squamous cell carcinoma. Cancer Lett (2004) 0.86
Telomere length is associated with types of chromosome 21 nondisjunction: a new insight into the maternal age effect on Down syndrome birth. Hum Genet (2010) 0.86
The occurrence of chromosome segregational defects is an intrinsic and heritable property of oral squamous cell carcinoma cell lines. Cancer Genet Cytogenet (2004) 0.85
Role of NK cells in host defense against pulmonary type A Francisella tularensis infection. Microbes Infect (2012) 0.85
A Likelihood-Based Approach for Missing Genotype Data. Hum Hered (2010) 0.85
Fluorescence immunophenotypic and interphase cytogenetic characterization of nodal lymphoplasmacytic lymphoma. Am J Surg Pathol (2008) 0.84
Efficient simulation of P values for linkage analysis. Genet Epidemiol (2004) 0.84